Related Experiment Video
Updated: Jan 20, 2026

Single-Cell Optical Action Potential Measurement in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Published on: December 22, 2020
Therapeutic Potential of an Endolysin Derived from Kayvirus S25-3 for Staphylococcal Impetigo
Ichiro Imanishi1, Jumpei Uchiyama2, Toshihiro Tsukui3
1Laboratory of Veterinary Internal Medicine, Division of Animal Life Science, Institute of Agriculture, Graduate School, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu, Tokyo 183-8509, Japan.
Abstract:
Impetigo is a contagious skin infection predominantly caused by Staphylococcus aureus. Decontamination of S. aureus from the skin is becoming more difficult because of the emergence of antibiotic-resistant strains. Bacteriophage endolysins are less likely to invoke resistance and can eliminate the target bacteria without disturbance of the normal microflora. In this study, we investigated the therapeutic potential of a recombinant endolysin derived from kayvirus S25-3 against staphylococcal impetigo in an experimental setting. First, the recombinant S25-3 endolysin required an incubation period of over 15 minutes to exhibit efficient bactericidal effects against S. aureus. Second, topical application of the recombinant S25-3 endolysin decreased the number of intraepidermal staphylococci and the size of pustules in an experimental mouse model of impetigo. Third, treatment with the recombinant S25-3 endolysin increased the diversity of the skin microbiota in the same mice. Finally, we revealed the genus-specific bacteriolytic effect of recombinant S25-3 endolysin against staphylococci, particularly S. aureus, among human skin commensal bacteria. Therefore, topical treatment with recombinant S25-3 endolysin can be a promising disease management procedure for staphylococcal impetigo by efficient bacteriolysis of S. aureus while improving the cutaneous bacterial microflora.
Insights
Recombinant S25-3 endolysin shows promise for treating staphylococcal impetigo. This enzyme effectively kills Staphylococcus aureus, reduces infection severity, and benefits skin microbiota.
Area of Science:
- Microbiology
- Dermatology
- Biotechnology
Background:
- Impetigo is a contagious skin infection often caused by Staphylococcus aureus.
- Antibiotic-resistant strains of S. aureus present treatment challenges.
- Bacteriophage endolysins offer a potential alternative due to low resistance development and preservation of beneficial microflora.
Purpose of the Study:
- To investigate the therapeutic potential of recombinant S25-3 endolysin against staphylococcal impetigo.
- To evaluate the efficacy and safety of endolysin treatment in an experimental setting.
Main Methods:
- Assessed bactericidal activity of recombinant S25-3 endolysin against S. aureus.
- Utilized an experimental mouse model to evaluate topical endolysin application for impetigo.
- Analyzed changes in intraepidermal staphylococci, pustule size, and skin microbiota diversity.
- Determined the genus-specific bacteriolytic effect of the endolysin on staphylococci and commensal bacteria.
Main Results:
- Recombinant S25-3 endolysin demonstrated efficient bactericidal effects against S. aureus after 15 minutes of incubation.
- Topical endolysin treatment reduced intraepidermal staphylococci and pustule size in the mouse model.
- Endolysin treatment led to increased skin microbiota diversity.
- The endolysin exhibited genus-specific lysis of staphylococci, particularly S. aureus, among skin commensals.
Conclusions:
- Recombinant S25-3 endolysin is a promising therapeutic agent for staphylococcal impetigo.
- Topical endolysin treatment effectively targets S. aureus while promoting a healthier skin microbiome.
- This approach offers a potential solution for managing impetigo, especially with rising antibiotic resistance.
More Related Videos
Related Concept Videos
Cell Potential and Free Energy
Thermodynamics is the branch of physics dealing with the relationship between heat and other forms of energy. In an electrochemical cell, chemical energy is converted into electrical energy.
Thus, a link can be predicted between cell potential, free energy change, and the equilibrium constant for the reaction. Cell potential can also be measured as the oxidant or the reducing strength, and similar acid-base strength measures are reflected in equilibrium...
Therapeutic Index
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Measurement: Derived Units
Standard Electrode Potentials
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...

